Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin

被引:51
作者
Noskin, GA
Siddiqui, F
Stosor, V
Kruzynski, J
Peterson, LR
机构
[1] NW Mem Hosp, Clin Microbiol Lab, Chicago, IL 60611 USA
[2] Northwestern Univ, Sch Med, Dept Med, Div Infect Dis, Chicago, IL 60611 USA
[3] Northwestern Univ, Sch Med, Dept Pathol, Div Clin Microbiol, Chicago, IL 60611 USA
关键词
D O I
10.1086/517221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:689 / 690
页数:2
相关论文
共 10 条
[1]   Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): A report of fifteen cases [J].
Dever, LL ;
Smith, SM ;
Dejesus, D ;
Masurekar, M ;
Patel, D ;
Kaminski, ZC ;
Johanson, WG .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1996, 2 (04) :407-413
[2]   Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality [J].
Edmond, MB ;
Ober, JF ;
Dawson, JD ;
Weinbaum, DL ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) :1234-1239
[3]   Treatment of vancomycin-resistant Enterococcus faecium infections [J].
Lai, KK .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (22) :2579-2584
[4]   THE LIFE AND TIMES OF THE ENTEROCOCCUS [J].
MURRAY, BE .
CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (01) :46-65
[5]  
National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
[6]   ENTEROCOCCUS-FAECIUM AND ENTEROCOCCUS-FAECALIS BACTEREMIA - ACQUISITION AND OUTCOME [J].
NOSKIN, GA ;
PETERSON, LR ;
WARREN, JR .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) :296-301
[7]   Vancomycin-resistant enterococci: Clinical, microbiologic, and epidemiologic features [J].
Noskin, GA .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (01) :14-20
[8]   TESTS FOR BACTERICIDAL EFFECTS OF ANTIMICROBIAL AGENTS - TECHNICAL PERFORMANCE AND CLINICAL RELEVANCE [J].
PETERSON, LR ;
SHANHOLTZER, CJ .
CLINICAL MICROBIOLOGY REVIEWS, 1992, 5 (04) :420-432
[9]   Enterococcus faecium bacteremia -: Does vancomycin resistance make difference? [J].
Stosor, V ;
Peterson, LR ;
Postelnick, M ;
Noskin, GA .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (05) :522-527
[10]   In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents [J].
Zurenko, GE ;
Yagi, BH ;
Schaadt, RD ;
Allison, JW ;
Kilburn, JO ;
Glickman, SE ;
Hutchinson, DK ;
Barbachyn, MR ;
Brickner, SJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :839-845